Overview
Distal myopathy 2 encompasses various genetic disorders characterized by muscle weakness predominantly affecting distal muscles, often associated with additional systemic manifestations such as cardiomyopathy. 1Diagnosis
Genetic Testing: Sequencing of FHL1 gene for mutations, particularly in cases with X-linked inheritance and features of distal myopathy with cardiomyopathy 1.
Muscle Biopsy: Reveals characteristic pathological features such as vacuolar changes; absence of reducing bodies may differentiate from other FHL1-related myopathies 1.
Cardiac Evaluation: Echocardiography to assess for hypertrophic cardiomyopathy, crucial in patients with suspected distal myopathy 2 1.
Autonomic Function Testing: Evaluate for altered peripheral vasomotor function, indicated by exaggerated systolic blood pressure response and blunted heart rate response during orthostatic challenges 2.Management
Symptomatic Treatment: Physical therapy to maintain muscle strength and function 12.
Cardiac Monitoring: Regular echocardiograms to manage hypertrophic cardiomyopathy complications 1.
Pharmacological Support: Specific drug classes and doses not detailed; focus on managing symptoms and complications as they arise 12.Special Populations
Pediatrics: Early recognition and genetic counseling are essential for families with a history of X-linked distal myopathy 1.
Comorbidities: Patients may require additional management for cardiovascular complications, emphasizing the importance of cardiac monitoring 1.Key Recommendations
Perform genetic testing focusing on FHL1 gene mutations in patients with X-linked distal myopathy and hypertrophic cardiomyopathy (Evidence: Strong 1).
Include autonomic function assessments in the evaluation of distal myopathy patients to identify peripheral vasomotor dysfunction (Evidence: Moderate 2).
Regular cardiac evaluations via echocardiography are recommended for monitoring and managing hypertrophic cardiomyopathy in distal myopathy 2 patients (Evidence: Moderate 1).References
1 D'Arcy C, Kanellakis V, Forbes R, Wilding B, McGrath M, Howell K et al.. X-linked Recessive Distal Myopathy With Hypertrophic Cardiomyopathy Caused by a Novel Mutation in the FHL1 Gene. Journal of child neurology 2015. link
2 Borg K, Sachs C, Kaijser L. Autonomic cardiovascular responses in distal myopathy (Welander). Acta neurologica Scandinavica 1987. link